Financials
- Market Capitalization 166.6789 M
- Employee 184
- Founded 2004
- CEO Laura Niklason
- Website www.humacyte.com
- Headquarter Delaware, United States
- FIGI BBG00XPPT7S7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.02
Relación precio/flujo de caja
0.8
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 6938 | SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0237 USD | -10.90% | -14.13% | +39.41% | -9.89% | 341.20 M USD | ||
| 7042 | YDESW YD Bio Limited - Warrants | 0.4375 USD | 0.00% | +25.00% | +75.00% | -56.25% | 276.08 M USD | ||
| 7151 | ENGNW enGene Therapeutics Inc. - Warrants | 0.2200 USD | +15.85% | -11.68% | -56.33% | -66.15% | 126.61 M USD | ||
| 7170 | FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.72 USD | +1.19% | +1.74% | -0.90% | +110.34% | 101.51 M USD |